
AstraZeneca stays mum on Medicare drug pricing negotiations
Medicare has started negotiating drug prices for the first time, but neither the government nor the drug makers are revealing details. Last week, Medicare made its first offers to 10 drug manufacturers, leaving it up to them to discuss the proposals. AstraZeneca executives did not disclose any details about the price negotiation for their diabetes…